Compare

Compare archived captures

This view highlights text differences between two archived captures. It does not interpret meaning or provide guidance.

Descriptive changes only

This comparison highlights text changes between archived captures. It does not interpret the change or provide medical advice. For up-to-date recommendations, always consult the official source website.

Need to cite this comparison? See /cite.

Earlier capture

Drug Products - Canada.ca

Apr 18, 2025

legacy-hc-2025-04-21

ID 217917

Later capture

Drug Products - Canada.ca

Jan 2, 2026

hc-20260101

ID 429113

updated2 sections changed
2 sections changed0 added0 removed+4 / -2 linesChange ratio: 1%
---
+++
@@ -259,6 +259,9 @@
publications-publications@hc-sc.gc.ca
.
Reports
+Statistical Report 2024/2025 for the Patented Medicines (Notice of Compliance) Regulations, Data Protection and Certificates of Supplementary Protection (To obtain a full electronic copy of this report, please contact
+publications-publications@hc-sc.gc.ca
+). [2025-07-25]
Statistical Report 2023/2024 for the Patented Medicines (Notice of Compliance) Regulations, Data Protection and Certificates of Supplementary Protection (To obtain a full electronic copy of this report, please contact
publications-publications@hc-sc.gc.ca
). [2024-08-13]
@@ -280,5 +283,4 @@
Stakeholder Workshop on a National Buprenorphine Program
[2004-12-06]
Page details
-Date modified:
-2024-08-13
+2025-07-25